Biotech Shares Rip Following FDA Designation Announcement
October 15 2024 - 12:00PM
AllPennyStocks.com
A Massachusetts-based biotech company is
stealing the show so far during Tuesday’s session after it
announced that its investigational drug IMM-1-104 has received
orphan...
To read the full story on AllPennyStocks.com, click
here.
Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Oct 2023 to Oct 2024